Janus Henderson Group
YARW

Janus Henderson Group’s Yarrow Bioscience YARW Stock Holding History

Janus Henderson Group’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-356
Closed -$5.94M – 1427
2019
Q4 		$5.94M Sell
356
-38
-10% -$633K ﹤0.01% 1026
2019
Q3 		$6.35M Sell
394
-8
-2% -$129K ﹤0.01% 1026
2019
Q2 		$8.68M Sell
402
-3
-0.7% -$74.2K ﹤0.01% 967
2019
Q1 		$11.4M Sell
405
-44
-10% -$1.06M 0.01% 896
2018
Q4 		$6.66M Sell
449
-116
-21% -$2.6M ﹤0.01% 937
2018
Q3 		$20M Sell
565
-1
-0.2% -$30.9K 0.01% 818
2018
Q2 		$16.5M Sell
566
-2
-0.4% -$77.7K 0.01% 843
2018
Q1 		$76.8M Buy
+568
New +$69.1M 0.05% 444

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group's YARW Position: Q1 2020 in Review

Janus Henderson Group sold out of Yarrow Bioscience (YARW) in Q1 2020, closing a stake of 356 shares — an estimated $5.94M sold.

Janus Henderson Group first reported a position in YARW in Q1 2018 and held it in 8 quarters. The position peaked at $76.8M in Q1 2018. 86 funds tracked by Wall St. Rank hold YARW as of Q1 2020.

  • Janus Henderson Group reported no remaining Yarrow Bioscience position as of Q1 2020 after selling out during the quarter.
  • Janus Henderson Group sold 356 Yarrow Bioscience shares in Q1 2020, an estimated $5.94M.
  • Janus Henderson Group first reported a position in Yarrow Bioscience in Q1 2018 and held it in 8 quarters.
  • Janus Henderson Group's Yarrow Bioscience position peaked at $76.8M in Q1 2018.
  • 86 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2020.

Based on Janus Henderson Group's 13F filing for Q1 2020, filed 14 May 2020.